Clinical trial
VELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following…
NCT00311337 · University of Wuerzburg, Other · Unknown status
Key facts
| NCT number | NCT00311337 |
|---|---|
| Title | VELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) |
| Official title | Evaluation of Safety and Efficacy of VELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following High-Dose Melphalan Treatment and Autologous PBSCT (Minimal Residual Disease, Partial Remission or Stable Disease) |
| Lead sponsor | University of Wuerzburg, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | bortezomib |
| Enrollment | 61 |
| Start date | Oct 1, 2005 |
| Completion | Oct 1, 2010 |
| First posted | Apr 5, 2006 |
| Last update posted | Apr 5, 2006 |
| Countries | Austria, Germany, Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: